Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21052089

A phase-2 trial of low-dose pomalidomide in myelofibrosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2011 Feb
First author
Begna KH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Begna KH
      type
      Author
    2. name
      Mesa RA
      type
      Author
    3. name
      Pardanani A
      type
      Author
    4. name
      Hogan WJ
      type
      Author
    5. name
      Litzow MR
      type
      Author
    6. name
      McClure RF
      type
      Author
    7. name
      Tefferi A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Begna KH
      type
      Author
    2. name
      Mesa RA
      type
      Author
    3. name
      Pardanani A
      type
      Author
    4. name
      Hogan WJ
      type
      Author
    5. name
      Litzow MR
      type
      Author
    6. name
      McClure RF
      type
      Author
    7. name
      Tefferi A
      type
      Author
    bibliography ids
    1. nci-bib-4a48785eb836663efcfb25d3
    book metadata
    content sha256
    2d5f187a38ce2e416a0227f3fa7787d243b128f43ea8bf02f9d547df69874800
    document type
    citation
    dois
    1. 10.1038/leu.2010.254
    electronic publication date
    display
    2010 Nov 5
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21052089
    immutable id
    pubmed:21052089@2d5f187a38ce2e416a0227f3fa7787d243b128f43ea8bf02f9d547df69874800
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    2
    name
    Leukemia
    nlm unique id
    8704895
    pages
    301-4
    volume
    25
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21052089
      provenance
      batch id
      edef4b7f1a2a505cd5a9
      provider
      NCBI PubMed ESummary
      record sha256
      4a965935fe9d9fb863825c37f149905cc7c279e20e039cd6cb854c249d3210a7
      response sha256
      d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
      retrieved at
      2026-09-09T23:46:38.027615+00:00
      publication date
      display
      2011 Feb
      precision
      month
      year
      2011
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21052089/
      title
      A phase-2 trial of low-dose pomalidomide in myelofibrosis.

      Preserved source evidence · Not medical advice